Renée Galá
President chez JAZZ PHARMACEUTICALS PLC
Fortune : 6 M $ au 30/04/2024
Profil
Actuellement, Rene D. Gal occupe le poste de directeur financier et vice-président exécutif de Jazz Pharmaceuticals Plc. Elle est également membre du conseil d'administration de Gossamer Bio, Inc. et de Gyroscope Therapeutics Ltd. Par le passé, elle a occupé les postes de directrice financière, trésorière et vice-présidente principale chez Theravance Biopharma, Inc. et directrice financière chez GRAIL, Inc. et vice-présidente des finances chez Innoviva, Inc. et directrice chez Eli Lilly & Company (Ireland) Ltd. Rene D. Gal a obtenu un diplôme de premier cycle à l'université Vanderbilt et un MBA à la Columbia Business School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 05/04/2024 | 55 357 ( 0,09% ) | 6 M $ | 30/04/2024 | |
GOSSAMER BIO, INC.
-.--% | 16/04/2024 | 0 ( -.--% ) | - $ | 30/04/2024 |
Postes actifs de Renée Galá
| Sociétés | Poste | Début |
|---|---|---|
| GOSSAMER BIO, INC. | Directeur/Membre du Conseil | 19/12/2018 |
| JAZZ PHARMACEUTICALS PLC | President | 01/10/2023 |
Jazz Pharmaceuticals Ireland Ltd.
 Jazz Pharmaceuticals Ireland Ltd. Pharmaceuticals: MajorHealth Technology Part of Jazz Pharmaceuticals Plc, Jazz Pharmaceuticals Ireland Ltd. is an Irish biopharmaceutical company that focuses on the identification, development, and commercialization of pharmaceutical products. The company is based in Dublin, Ireland. The company was founded by Bruce C. Cozadd, who has been the CEO since incorporation. | President | 01/01/2020 |
Anciens postes connus de Renée Galá
| Sociétés | Poste | Fin |
|---|---|---|
Jazz Pharmaceuticals, Inc.
 Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA. | Directeur Financier/CFO | 01/03/2024 |
| GYROSCOPE THERAPEUTICS HOLDINGS PLC | Directeur/Membre du Conseil | 17/02/2022 |
Gyroscope Therapeutics Ltd.
 Gyroscope Therapeutics Ltd. BiotechnologyHealth Technology Gyroscope Therapeutics Ltd. operates as an ophthalmology firm. It develops a cutting edge, genetically-defined therapies for the treatment of eye diseases linked to an unbalanced complement system. The company was founded on April 18, 2016 and is headquartered in Stevenage, the United Kingdom. | Directeur/Membre du Conseil | 01/02/2022 |
GRAIL LLC
 GRAIL LLC Electronic Equipment/InstrumentsElectronic Technology GRAIL LLC is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA. | Directeur Financier/CFO | 06/06/2019 |
| CORCEPT THERAPEUTICS INCORPORATED | Directeur/Membre du Conseil | 01/06/2019 |
Formation de Renée Galá
| Vanderbilt University | Undergraduate Degree |
| Columbia Business School | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 5 |
|---|---|
| INNOVIVA, INC. | Health Technology |
| THERAVANCE BIOPHARMA, INC. | Health Technology |
| CORCEPT THERAPEUTICS INCORPORATED | Health Technology |
| GOSSAMER BIO, INC. | Health Technology |
| JAZZ PHARMACEUTICALS PLC | Health Technology |
| Entreprise privées | 6 |
|---|---|
GRAIL LLC
GRAIL LLC Electronic Equipment/InstrumentsElectronic Technology GRAIL LLC is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA. | Electronic Technology |
Gyroscope Therapeutics Ltd.
Gyroscope Therapeutics Ltd. BiotechnologyHealth Technology Gyroscope Therapeutics Ltd. operates as an ophthalmology firm. It develops a cutting edge, genetically-defined therapies for the treatment of eye diseases linked to an unbalanced complement system. The company was founded on April 18, 2016 and is headquartered in Stevenage, the United Kingdom. | Health Technology |
Eli Lilly & Company (Ireland) Ltd.
 Eli Lilly & Company (Ireland) Ltd. Medical DistributorsDistribution Services Part of Eli Lilly & Co., Eli Lilly & Company (Ireland) Ltd. is an Irish pharmaceutical company that focuses on creating medicines to improve people's lives globally. The company is based in Dublin, Ireland. The company partners with government and regulatory agencies to ensure the safety of patients who use their medicines. Eli Lilly & Company has been a leader in the fight against Alzheimer's disease for over 30 years and conducts clinical development and research ethics to improve their products. | Distribution Services |
Gyroscope Therapeutics Holdings Plc
 Gyroscope Therapeutics Holdings Plc BiotechnologyHealth Technology Gyroscope Therapeutics Holdings Plc engages in the development of gene therapy beyond rare diseases. It focuses on age-related macular degeneration. The company was founded in 2016 and is headquartered in Stevenage, the United Kingdom. | Health Technology |
Jazz Pharmaceuticals, Inc.
Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA. | Health Technology |
Jazz Pharmaceuticals Ireland Ltd.
Jazz Pharmaceuticals Ireland Ltd. Pharmaceuticals: MajorHealth Technology Part of Jazz Pharmaceuticals Plc, Jazz Pharmaceuticals Ireland Ltd. is an Irish biopharmaceutical company that focuses on the identification, development, and commercialization of pharmaceutical products. The company is based in Dublin, Ireland. The company was founded by Bruce C. Cozadd, who has been the CEO since incorporation. | Health Technology |
